168
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours

, , , , &
Pages 575-589 | Received 26 Aug 2002, Accepted 04 Apr 2003, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now
Michael R. Horsman. (2015) Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation. International Journal of Hyperthermia 31:5, pages 453-459.
Read now
Nicolas D. Winter, Ryan K.J. Murphy, Thomas V. O’Halloran & George C. Schatz. (2011) Development and modeling of arsenic-trioxide–loaded thermosensitive liposomes for anticancer drug delivery. Journal of Liposome Research 21:2, pages 106-115.
Read now
Michael R. Horsman. (2008) Angiogenesis and vascular targeting: Relevance for hyperthermia. International Journal of Hyperthermia 24:1, pages 57-65.
Read now
Olav Dahl, Erling Dahl Borkamo & Øystein Fluge. (2008) Current status of antivascular therapy and targeted treatment in the clinic. International Journal of Hyperthermia 24:1, pages 97-110.
Read now
>Nagraj G. Huilgol. (2006) A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer. International Journal of Hyperthermia 22:5, pages 391-397.
Read now
Michael R. Horsman. (2006) Tissue physiology and the response to heat. International Journal of Hyperthermia 22:3, pages 197-203.
Read now

Articles from other publishers (25)

Mahmoud A. El-Ghiaty, Mohammed A. Alqahtani & Ayman O.S. El-Kadi. (2022) Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: A role of heme oxygenase 1. Chemico-Biological Interactions 364, pages 110049.
Crossref
Na Xie & Canhua Huang. 2021. Oxidative Stress. Oxidative Stress 237 262 .
Peter M. Corry & Robert J. Griffin. (2020) A Radiation Mitigator as a Potential Treatment for COVID-19. Radiation Research 193:6, pages 505.
Crossref
She-Ling Xie, Meng-Hang Yang, Kun Chen, Hai Huang, Xue-Wei Zhao, Yuan-Sheng Zang & Bing Li. (2014) Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer. Cell Biochemistry and Biophysics 71:3, pages 1325-1333.
Crossref
Richard W. Ahn, Susan L. Barrett, Meera R. Raja, Jennifer K. Jozefik, Lidia Spaho, Haimei Chen, Marcel B. Bally, Andrew P. Mazar, Michael J. Avram, Jane N. Winter, Leo I. Gordon, Lonnie D. Shea, Thomas V. O’Halloran & Teresa K. Woodruff. (2013) Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo. PLoS ONE 8:3, pages e58491.
Crossref
Clarisse S. Muenyi, Allan R. Pinhas, Teresa W. Fan, Guy N. Brock, C. William Helm & J. Christopher States. (2012) Sodium Arsenite ± Hyperthermia Sensitizes p53-Expressing Human Ovarian Cancer Cells to Cisplatin by Modulating Platinum-DNA Damage Responses. Toxicological Sciences 127:1, pages 139-149.
Crossref
Yonggang Lv, Yang Zou & Li Yang. (2011) Theoretical model for thermal protection by microencapsulated phase change micro/nanoparticles during hyperthermia. Heat and Mass Transfer 48:4, pages 573-584.
Crossref
Caroline Diepart, Oussama Karroum, Julie Magat, Olivier Feron, Julien Verrax, Pedro Buc Calderon, Vincent Grégoire, Philippe Leveque, Julie Stockis, Nicolas Dauguet, Bénédicte F. Jordan & Bernard Gallez. (2012) Arsenic Trioxide Treatment Decreases the Oxygen Consumption Rate of Tumor Cells and Radiosensitizes Solid Tumors. Cancer Research 72:2, pages 482-490.
Crossref
Nak Jong SeongChang Jin YoonSung-Gwon KangJin Wook ChungHyo-Cheol KimJae Hyung Park. (2012) Effects of Arsenic Trioxide on Radiofrequency Ablation of VX2 Liver Tumor: Intraarterial versus Intravenous Administration. Korean Journal of Radiology 13:2, pages 195.
Crossref
Robert J. Griffin, Brent W. Williams, Nathan A. Koonce, John C. Bischof, Chang W. Song, Rajalakshmi Asur & Meenakshi Upreti. (2012) Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors. Journal of Oncology 2012, pages 1-7.
Crossref
Clarisse S Muenyi, Vanessa A States, Joshua H Masters, Teresa W Fan, C William Helm & J Christopher States. (2011) Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC). Journal of Ovarian Research 4:1.
Crossref
Mithun M Shenoi, Neha B Shah, Robert J Griffin, Gregory M Vercellotti & John C Bischof. (2011) Nanoparticle preconditioning for enhanced thermal therapies in cancer. Nanomedicine 6:3, pages 545-563.
Crossref
Hui Yu, Guang-Yu Zhu, Rui-Zhi Xu, Huan-Zhang Niu, Qin Lu, Guo-Zhao Li, Zi-Yu Wang, Dong-Sheng Zhang, Ning Gu & Gao-Jun Teng. (2011) Arterial Embolization Hyperthermia Using As2O3 Nanoparticles in VX2 Carcinoma–Induced Liver Tumors. PLoS ONE 6:3, pages e17926.
Crossref
Graeme J. Dougherty & David J. Chaplin. 2010. Vascular Disruptive Agents for the Treatment of Cancer. Vascular Disruptive Agents for the Treatment of Cancer 1 27 .
J Shen. (2008) Effects of arsenic trioxide on apoptosis and proliferation of human lung cancer cells under hypoxia. Journal of Chinese Integrative Medicine 6:3, pages 274-277.
Crossref
Adel AbdellaouiAnthony F Watkinson. (2008) Radiofrequency ablation of renal tumors. Future Oncology 4:1, pages 103-111.
Crossref
Robert J. Griffin, Brent W. Williams, John C. Bischof, Michael Olin, Gary L. Johnson & Brian W. Lee. (2016) Use of a Fluorescently Labeled Poly-Caspase Inhibitor for in Vivo Detection of Apoptosis Related to Vascular-Targeting Agent Arsenic Trioxide for Cancer Therapy . Technology in Cancer Research & Treatment 6:6, pages 651-654.
Crossref
Shih-Chieh Chen, Ming-Hsien Tsai, Hsiu-Jen Wang, Hsin-Su Yu & Louis W. Chang. (2007) Involvement of Substance P and Neurogenic Inflammation in Arsenic-Induced Early Vascular Dysfunction. Toxicological Sciences 95:1, pages 82-88.
Crossref
Peter Kovacic. (2007) Unifying mechanism for anticancer agents involving electron transfer and oxidative stress: Clinical implications. Medical Hypotheses 69:3, pages 510-516.
Crossref
Michael R. Horsman & Dietmar W. Siemann. (2006) Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies. Cancer Research 66:24, pages 11520-11539.
Crossref
John C. Bischof. (2006) Micro and nanoscale phenomenon in bioheat transfer. Heat and Mass Transfer 42:10, pages 955-966.
Crossref
Andrew Hines-Peralta, Vikas Sukhatme, Meredith Regan, Sabina Signoretti, Zheng-jun Liu & S. Nahum Goldberg. (2006) Improved Tumor Destruction with Arsenic Trioxide and Radiofrequency Ablation in Three Animal Models. Radiology 240:1, pages 82-89.
Crossref
Rachana K. Visaria, Robert J. Griffin, Brent W. Williams, Emad S. Ebbini, Giulio F. Paciotti, Chang W. Song & John C. Bischof. (2006) Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery. Molecular Cancer Therapeutics 5:4, pages 1014-1020.
Crossref
Robert J. Griffin, Brent W. Williams, Heon Joo Park & Chang W. Song. (2005) Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. International Journal of Radiation Oncology*Biology*Physics 61:5, pages 1516-1522.
Crossref
Robert J. Griffin, Brent W. Williams, Kenneth P. Roberts, David J. Swanlund & John C. Bischof. (2016) Assessing pH and Oxygenation in Cryotherapy-induced Cytotoxicity and Tissue Response to Freezing. Technology in Cancer Research & Treatment 3:3, pages 245-251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.